Publications by authors named "Magdalena Dank"

Claim this Profile
B
Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial.
Christoph Zielinski, István Láng, Moshe Inbar, Zsuzsanna Kahán, Richard Greil, Magdalena Dank

Lancet Oncol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life of palliative chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction treated with irinotecan combined with 5-fluorouracil and folinic acid: results of a randomised phase III trial.
Desmond Curran, Carmelo Pozzo, Jerzy Zaluski, Magdalena Dank, Carlo Barone

Qual Life Res· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis